A carregar...

A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacy

The in vivo therapeutic efficacy of DC-based cancer vaccines is limited by suboptimal DC maturation protocols. Although delivery of TLR adjuvants systemically boosts DC-based cancer vaccine efficacy, it could also increase toxicity. Here, we have engineered a drug-inducible, composite activation rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Narayanan, Priyadharshini, Lapteva, Natalia, Seethammagari, Mamatha, Levitt, Jonathan M., Slawin, Kevin M., Spencer, David M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3069772/
https://ncbi.nlm.nih.gov/pubmed/21383499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI44327
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!